← Open Payments lookup

KACIE BLACKWELL: Open Payments

NPI 1427400217 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$712 in 36 payments from 17 companies in 2025. Trend: 2023 $72 · 2024 $985 · 2025 $712

Food & beverage: $712
CompanyPaymentsAmount
GlaxoSmithKline, LLC.7$143
Lilly USA, LLC4$73
Takeda Pharmaceuticals U.S.A., Inc.3$68
Boston Scientific Corporation1$53
Phathom Pharmaceuticals, Inc.3$48
AstraZeneca Pharmaceuticals LP3$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$39
Amgen Inc.2$38
Antares Pharma, Inc.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33

Products named: TRELEGY ELLIPTA, TRINTELLIX, MOUNJARO, AMS 700, VOQUEZNA, BREZTRI, SHINGRIX, XIFAXAN.

Industry payments across LA — which companies pay providers there.